United Therapeutics (UTHR) Current Deferred Tax Assets (2009 - 2013)

United Therapeutics (UTHR) has 5 years of Current Deferred Tax Assets data on file, last reported at $14.6 million in Q2 2013.

• For the quarter ending Q2 2013, Current Deferred Tax Assets rose 77.51% year-over-year to $14.6 million; the trailing twelve-month figure through Jun 2013 stood at $14.6 million (up 77.51% YoY), and the FY2012 full-year result was $14.6 million, up 77.51% from the prior year.
• Current Deferred Tax Assets steadied at $14.6 million in Q2 2013, from $14.6 million in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $14.6 million in Q4 2012 to a low of $2.3 million in Q1 2011.
• A 5-year average of $9.0 million and a median of $8.2 million in 2011 frame the typical range for Current Deferred Tax Assets.
• Across the five-year window, Current Deferred Tax Assets tumbled 80.39% in 2011 and surged 255.09% in 2012, its largest moves.
• Tracing UTHR's Current Deferred Tax Assets over 5 years: stood at $7.2 million in 2009, then surged by 74.99% to $12.6 million in 2010, then plunged by 34.85% to $8.2 million in 2011, then surged by 77.51% to $14.6 million in 2012, then changed by 0.0% to $14.6 million in 2013.
• Business Quant data shows UTHR's Current Deferred Tax Assets at $14.6 million in Q2 2013, $14.6 million in Q1 2013, and $14.6 million in Q4 2012.